Table 4.
Categorical Distribution of UACR before and after IVB
| Category of UACR | All Patients | Diabetic Patients | ||||
|---|---|---|---|---|---|---|
| Control | DM | P Value | NPDR | PDR | P Value | |
| Pre-IVB | <0.001* | 0.120 | ||||
| A1 (< 30 mg/g, normal) | 33 (89%) | 17 (32%) | 10 (38%) | 7 (26%) | ||
| A2 (≥ 30 and ≤ 300 mg/g) | 4 (11%) | 20 (38%) | 11 (29%) | 9 (33%) | ||
| A3 (> 300 mg/g) | 0 | 16 (30%) | 5 (19%) | 11 (41%) | ||
| Post-IVB | <0.001* | 0.712 | ||||
| A1 (< 30 mg/g, normal) | 33 (89%) | 16 (30%) | 7 (27%) | 9 (33%) | ||
| A2 (≥ 30 and ≤ 300 mg/g) | 4 (11%) | 23 (43%) | 14 (54%) | 9 (33%) | ||
| A3 (> 300 mg/g) | 0 | 14 (26%) | 5 (19%) | 9 (33%) | ||
| Categorical change† | 0.782 | 0.021* | ||||
| Improved change | 0 | 5 (9%) | 1 (4%) | 4 (15%) | ||
| No change of category | 37 (100%) | 44 (83%) | 21 (81%) | 23 (85%) | ||
| Aggravated change | 0 | 4 (8%) | 4 (15%) | 0 | ||
Data are expressed as number (percentage).
*
P value < 0.05 by χ2 test.
†
Improved change included change from A3 to A1 or A2 and A2 to A1, whereas aggravated changes included change from A1 to A2 or A3 and A2 to A3.